Lamotrigine

Lamotrigine

Status	Commercial
Therapeutic cat.	Neurology
Polymorphic form	Anhydrous monoclinic
CAS No.	84057-84-1
EU DMF readiness
CEP
CHINESE  DMF
JAPANESE DMF
KOREAN  DMF
US DMF readiness

Drug description

Lamotrigine is an anti-epileptic medication, also called an anticonvulsant. Lamotrigine is used alone or with other medications to treat epileptic seizures in adults and children. Lamotrigine is also used to delay mood episodes in adults with bipolar disorder (manic depression). Immediate-release lamotrigine can be used in children as young as 2 years old when it is given as part of a combination of seizure medications. However, this form should not be used as a single medication in a child or teenager who is younger than 16 years old. Extended-release lamotrigine is for use only in adults and children who are at least 13 years old. Lamotrigine may also be used for purposes not listed in this medication guide.

Disclaimer:  Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).